Skip to main content

Publisher: Taylor and Francis Ltd

Volume 14, Numbers 5-6, Numbers 5-6/October-December 2003

Favourites:
ADD

e-Molecular shapes and properties
pp. 329-337(9)
Authors: Carpy, A.J.M.; Marchand-Geneste, N.

Favourites:
ADD

Prediction of Biological Activity Spectra via The Internet
pp. 339-347(9)
Authors: Sadym, A.; Lagunin, A.; Filimonov, D.; Poroikov, V.

Favourites:
ADD

Zherlock: An Open Source Data Analysis Software
pp. 349-360(12)
Authors: Alsberg, B.K.; Kirkhus, L.; Hagen, R.; Knudsen, Ø.; Tangstad, T.; Anderssen, E.

Favourites:
ADD

In silico modelling of hazard endpoints: current problems and perspectives
pp. 361-371(11)
Authors: Mekenyan, O.; Dimitrov, S.; Schmieder, P.; Veith, G.

Favourites:
ADD
Favourites:
ADD

Comparative toxicity and hazards of pesticides to Apis and non-Apis bees. A chemometrical study
pp. 389-403(15)
Authors: Devillers, J.; Decourtye, A.; Budzinski, H.; Pham-Delègue, M.H.; Cluzeau, S.; Maurin, G.

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

New Fuzzy Logic Strategies for Bio-molecular Recognition
pp. 421-431(11)
Authors: Exner, T.E.; Keil, M.; Brickmann, J.

Favourites:
ADD

Comparison of MLR, PLS and GA-MLR in QSAR analysis*
pp. 433-445(13)
Authors: Saxena, A.K.; Prathipati, P.

Favourites:
ADD

QSAR studies on P-glycoprotein-regulated multidrug resistance and on its reversal by phenothiazines*
pp. 447-454(8)
Authors: Dearden, J.C.; Al-Noobi, A.; Scott, A.C.; Thomson, S.A.

Favourites:
ADD

Comparative study of non nucleoside inhibitors with HIV-1 reverse transcriptase based on 3D-QSAR and docking
pp. 455-474(20)
Authors: Chen, H.F.; Yao, X.J.; Li, Q.; Yuan, S.G.; Panaye, A.; Doucet, J.P.; Fan, B.T.

Favourites:
ADD
Favourites:
ADD

Study of local anesthetic activity of some derivatives of 3-amino-BENZO-[d]-Isothiazole
pp. 485-495(11)
Authors: Geronikaki, A.; Vicini, P.; Theophilidis, G.; Lagunin, A.; Poroikov, V.; Dearden, J.C.

Favourites:
ADD

Referees for Volume 14
pp. 497-498(2)

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content